Your browser does not support JavaScript or it may be disabled!
rediff.com
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
NEWS ON MOBILE
Get Realtime News
on your webpage

About 739 results for "erbitux"

Merck KGaA Names Pharmaceutical Head Oschmann Deputy CEO

Merck KGaA, the German maker of Erbitux cancer medicine, promoted Stefan Oschmann to deputy chief executive officer and appointed Belen Garijo as its first female board member. Oschmann, currently head of the pharmaceutical unit, and Garijo, now ... BusinessWeek, 2 months ago

Putting the Patient First: Merck Serono to Present Data That Embodies the ESMO 2014 Theme of

ESMO 2014 Abstract #: Physician biomarker survey: 1080O_PR; Erbitux: CRYSTAL: 541P; LASCCHN: 993PD; DIRECT: 996P; Pipeline: pimasertib: 443O; c-Met: 1333TiP, 450PD, 744TiP, 745TiP; further pipeline: 772P, 507PD, 1235P ...
 Newswit.com1 month ago Merck KGaA : Putting the Patient First: Merck Serono to Present Data That Embodies the ESMO 2014 Theme of Precision Medicine in Cancer Care  4 Traders1 month ago Merck on Track with Pharma Strategy  Bionity.com2 months ago Merck KGaA : on Track with Pharma Strategy; Pipeline Progress Announced  4 Traders2 months ago
[x]  

Eli Lilly : Trademark Application for "ERBITUX CETUXIMAB" Filed

By a News Reporter-Staff News Editor at Pharma Business Week -- According to news reporting originating from Washington, D.C. , by NewsRx journalists, a trademark application has been made for "ERBITUX CETUXIMAB" by Robert E. Lee , Jr., representing ...
 4 Traders1 month ago Researchers Submit Patent Application, "Predicting Response to Egfr Inhibitors", for Approval  4 Traders2 weeks ago Genovis : Researchers Submit Patent Application, "Endoglycosidase from Streptococcus Pyogenes and Methods Using It", for Approval  4 Traders1 month ago

Antibodies in Oncology Drug Pipeline Update 2014

The commercial and therapeutic success of antibodies like Rituxan, Avastin, and Erbitux will force the industry to look into the next generation of therapeutic antibodies, preparing themselves for the second wave in the lucrative field of ...
 Global Information Inc2 weeks ago
Securities Technology Monitor

Advaxis Appoints David J. Mauro, M.D., Ph.D., as Chief Medical Officer

Former Executive Director, Section Head Oncology Clinical Development at Merck & Co., Inc. and Director of Erbitux Medical Strategy at Bristol-Myers Squibb to Oversee Advaxis's Clinical Programs PRINCETON, N.J., Oct. 20, 2014 (GLOBE NEWSWIRE) -- ...
 Securities Technology Monitor1 month ago Advaxis, Inc. Appoints David J. Mauro, M.D., Ph.D., As Chief Medical Officer  FierceBiotech4 weeks ago Advaxis, Inc. Appoints As Chief Medical Officer  BioSpace1 month ago Advaxis : Appoints David J. Mauro, M.D., Ph.D., as Chief Medical Officer  4 Traders1 month ago
[x]  

TrovaGene Cancer Technology Detects KRAS Mutation

TrovaGene, Inc. ( TROV ) recently unveiled clinical study results that reflect the capability of its Precision Cancer Monitoring technology in detecting and monitoring KRAS mutation in circulating tumor DNA (ctDNA). The study compared the amount ...
 Yahoo! Finance1 day ago
Nasdaq

Trovagene Releases Clinical Study Results for the Detection and Monitoring of KRAS Mutations in Circulating Tumor DNA of Colorectal Cancer Patients

BARCELONA , Nov. 20, 2014 /PRNewswire/ --Trovagene, Inc., ( NASDAQ: TROV ) a developer of cell-free molecular diagnostics, announced today clinical study results highlighting the Company's ability to detect and quantitate KRAS mutations in blood and ...
 SearchBug2 days ago TROVAGENE : Releases Clinical Study Results for the Detection and Monitoring of KRAS Mutations in Circulating Tumor DNA of Colorectal Cancer Patients  4 Traders1 day ago TrovaGene, Inc. Releases Clinical Study Results For The Detection And Monitoring Of KRAS Mutations In Circulating Tumor DNA Of Colorectal Cancer Patients  BioSpace2 days ago
[x]  
EuroInvestor

Genclis SAS anime une table ronde aux 2èmes Rencontres Francophones d'Allergologie Moléculaire

Nancy, France, le 20 novembre 2014 : Genclis, société de diagnostic moléculaire dans les domaines de l'allergie et du cancer, sera présente les 22 et 23 novembre prochains aux 2èmes Rencontres Francophones d'Allergologie Moléculaire à Paris ( ...
 Sante Log2 days ago Genclis SAS Coordinate a Roundtable in a Molecular Allergology Seminar  Financial Content2 days ago
[x]  

Project Innovation Launches the Cancer Medicines Interactive Timeline to Highlight the Need for Continued Cancer Innovation in the U.S.

WASHINGTON , Nov. 20, 2014 /PRNewswire-USNewswire/ --In recognition of decades of medical progress in the country's fight against cancer, a national group of healthcare stakeholders called the Cancer Innovation Coalition (CIC) today launched the ...
 RCL Advisors2 days ago
[x]  
US News & World Report

Right-to-Try Laws Allowing Patients to Try Experimental Drugs, Bypass FDA

Christine McSherry's son Jett is a typical college freshman trying to push for as much independence as he can. But Duchenne muscular dystrophy, a disease that tears away muscles, has taken his ability to walk. He relies dailyon aides to help ...
 US News & World Report4 days ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
1.
2.
3.
4.
5.
6.
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts

Get

Realtime News

on your Webpage

Add Widget >Get your members hooked!
    
Alerts
Get updated on latest news & your favorite topics right in your inbox!
 
More     Less